Retraction of Crystallization Engineering in Aza-Steroid: Application in the Development of Finasteride

    August 2016 in “ Organic Process Research & Development ”
    Apurba Bhattacharya, Kushal Surajmal Manudhane, Srinivasula Reddy Maddula, Bukkapattanam R. Sreekanth, Sridhar Thota, Rakeshwar Bandichhor
    Image of study
    TLDR Authors retracted paper due to errors in data and mislabeling.
    The authors of a paper titled "Crystallization Engineering in Aza-Steroid: Application in the Development of Finasteride" have retracted their paper due to errors in the reported data. The IR spectrum labeled as finasteride was actually dihydrofinasteride, the XRD data for a different form of finasteride was included, and the ¹³C NMR spectrum for finasteride was mislabeled. Additionally, the CIF file for the finasteride structure was not included in the Supporting Information as intended. There is no evidence of intentional data manipulation. The paper was originally published on October 31, 2012, and retracted on August 25, 2016.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Post FUE finasteride - moved from oral to topical

      in Finasteride  90 upvotes 1 week ago
      The user switched from oral to topical finasteride with minoxidil after a hair transplant and is experiencing increased hair growth in unexpected areas like eyebrows and sideburns. They are seeking feedback from others with similar experiences.

      community Temporary alternative to finasteride?

      in Finasteride  100 upvotes 1 month ago
      A 23-year-old male plans to temporarily stop finasteride to donate plasma for financial reasons and seeks alternative hair loss treatments like minoxidil, ketoconazole, or RU58841 during this period. He is open to suggestions to prevent further hair loss until he can resume finasteride.

    Similar Research

    5 / 1000+ results